EYE 2.78% 18.5¢ nova eye medical limited

Ann: ELX Investor Presentation FY15 Results, page-2

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 4,696 Posts.
    lightbulb Created with Sketch. 72
    I do like the positive outlook repeated here. Not something that I remember this company doing in the past.

    Growth Strategy and Outlook

    "Growth Strategy and Outlook Ellex is entering a phase of rapid growth and, subject to A$ to US$ exchange rate and worldwide economic conditions, expects to achieve in FY16 a continuation of the revenue growth rates recently achieved and to continue to improve profitability. Beyond FY16, underlying industry growth is strong and 2RTTM , iTrack™ and SLT products provide transformational growth opportunities. "
 
watchlist Created with Sketch. Add EYE (ASX) to my watchlist
(20min delay)
Last
18.5¢
Change
0.005(2.78%)
Mkt cap ! $42.37M
Open High Low Value Volume
18.5¢ 19.0¢ 18.5¢ $30.78K 164.0K

Buyers (Bids)

No. Vol. Price($)
2 129999 18.5¢
 

Sellers (Offers)

Price($) Vol. No.
19.5¢ 108370 2
View Market Depth
Last trade - 16.10pm 07/10/2024 (20 minute delay) ?
EYE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.